Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Omnicell Company

OMCL
US68213N1090
632313

Price

42.62
Today +/-
+0.46
Today %
+1.18 %
P

Omnicell stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Omnicell stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Omnicell stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Omnicell stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Omnicell's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Omnicell Stock Price History

DateOmnicell Price
10/11/202442.62 undefined
10/10/202442.12 undefined
10/9/202442.95 undefined
10/8/202443.04 undefined
10/7/202442.25 undefined
10/4/202442.39 undefined
10/3/202441.51 undefined
10/2/202442.30 undefined
10/1/202442.38 undefined
9/30/202443.60 undefined
9/27/202443.02 undefined
9/26/202442.33 undefined
9/25/202442.55 undefined
9/24/202442.94 undefined
9/23/202444.06 undefined
9/20/202444.62 undefined
9/19/202443.42 undefined
9/18/202442.78 undefined
9/17/202444.92 undefined
9/16/202444.87 undefined

Omnicell Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Omnicell, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Omnicell from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Omnicell’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Omnicell. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Omnicell’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Omnicell’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Omnicell’s growth potential.

Omnicell Revenue, EBIT and net profit per share

DateOmnicell RevenueOmnicell EBITOmnicell Net Income
2029e2.26 B undefined0 undefined0 undefined
2028e1.92 B undefined0 undefined0 undefined
2027e1.67 B undefined0 undefined0 undefined
2026e1.23 B undefined70.53 M undefined85.14 M undefined
2025e1.17 B undefined71.16 M undefined74.66 M undefined
2024e1.11 B undefined63.01 M undefined64.3 M undefined
20231.15 B undefined-19.33 M undefined-20.37 M undefined
20221.3 B undefined20.5 M undefined5.6 M undefined
20211.13 B undefined91.5 M undefined77.8 M undefined
2020892.2 M undefined45.5 M undefined32.2 M undefined
2019897 M undefined78.4 M undefined61.3 M undefined
2018787.3 M undefined44.4 M undefined37.7 M undefined
2017712.7 M undefined11.1 M undefined30.5 M undefined
2016695.9 M undefined21.4 M undefined9.8 M undefined
2015484.6 M undefined45.2 M undefined30.8 M undefined
2014440.9 M undefined49.6 M undefined30.5 M undefined
2013380.6 M undefined35.3 M undefined24 M undefined
2012314 M undefined27.1 M undefined16.2 M undefined
2011245.5 M undefined16.2 M undefined10.4 M undefined
2010222.4 M undefined10.7 M undefined4.9 M undefined
2009213.5 M undefined3.2 M undefined400,000 undefined
2008251.9 M undefined17.3 M undefined12.7 M undefined
2007213.1 M undefined18.2 M undefined43.3 M undefined
2006154.7 M undefined9.3 M undefined10.4 M undefined
2005121.5 M undefined-2.3 M undefined-2.1 M undefined
2004123.9 M undefined10.7 M undefined10.6 M undefined

Omnicell Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
0.010.020.040.050.060.070.090.090.10.120.120.150.210.250.210.220.250.310.380.440.480.70.710.790.90.891.131.31.151.111.171.231.671.922.26
-200.0071.4333.3314.5821.8228.361.1617.2420.59-1.6327.2738.3117.84-15.144.2310.3628.1621.0215.7910.0043.602.4510.5313.98-0.5626.9114.40-11.43-3.054.955.2335.9914.9717.55
28.5747.6252.7862.5038.1859.7062.7958.6257.8457.7255.3755.1953.0551.0049.7753.1555.1054.1453.4252.9551.0345.6144.6647.2748.6146.5249.0346.1043.50------
21019302140545159716785113128106118135170203233247317318372436415555597499000000
-12-11-100-23-160-3810-291817310162735494521114478459120-19637170000
-171.43-52.38-27.78--41.82-23.88--3.457.848.13-1.655.848.456.771.414.506.538.609.2111.149.303.021.545.598.705.048.041.54-1.665.676.085.70---
-12-10-100-26-20-1-5710-2104312041016243030930376132775-20647485000
--16.67----23.08-95.00400.00-240.0042.86-120.00-600.00330.00-72.09--150.0060.0050.0025.00--70.00233.3323.3364.86-47.54140.63-93.51-500.00-420.0015.6314.86---
0.911.1111.51.710.321.725.327.725.928.933.833.132.133.534.134.235.836.636.736.938.740.642.943.747.945.945.21000000
-----------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Omnicell Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Omnicell is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (B)TOTAL CAPITAL (B)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                   
22.16.71223.821.533.530.629.560.9169.8120.4169.2183.7199.962.3104.5125.982.254.532.467.2127.2496.2359.7341.8490.49
14.39.71118.210.614.52229.53437.55840.842.738.755.158.682.8108150.3190196.2218.4190.1240.9299.5252.03
00001.72.82.80000000000000000000
4.89.310.412.712.78.814.613.815.713.71310.59.818.126.931.531.646.669.396.1100.910896.3119.9147.5110.1
1.21.92.74.83.647.78.617.231.133.630.228.42736.439.243.227.441.333.732.829.746.860.29374.96
42.427.636.159.550.163.677.781.4127.8252.1225250.7264.6283.7180.7233.8283.5264.2315.4352.2397.1483.3829.4780.7881.8927.57
2.87.24.95.454.85.74.75.210.216.213.214.417.334.135.336.232.34242.651.5110.4114.2119.7132133.59
000.20.20.40.30.44.912.913.411.310.69.68.813.212.211.714.520.615.417.119.822.218.432.942.95
001.75.16.46.46.51.30.70.20000000009.516.512.317.218.114.711.85
00.30.91.14.54.35.44.62.910.28.38.410.14.285.697.6104115.7223.5206.7200.5209.9262.2374.6323.7277.83
00000.42.12.13.13.123.1252528.528.5111.4111.3122.7147.9327.7337.8335.9336.5499.3738.9734.3735.81
1.220.10.94.12.91.50.5219.222.814.41621.416.82.32.24.25.952.162.768.78092.191.397.27
00.010.010.010.020.020.020.020.030.080.080.070.080.080.260.260.280.310.620.660.680.7611.361.331.3
0.050.040.040.070.070.080.10.10.150.330.310.320.340.360.440.490.560.580.941.021.081.241.822.142.212.23
                                                   
60.651.484.2000000000000000000.10.10.10.10.10.06
00-00.110.120.130.130.140.160.280.320.320.340.360.380.420.460.490.530.590.680.780.921.021.051.12
-45.6-73.5-92.8-94-99-91.7-81.1-83.2-72.8-30.1-17.4-16.9-12-1.614.538.56999.8100.4159.7197.5258.8290.7368.6390.7370.36
00-1,800-700-200000000000100200-1,400-2,700-9,500-6,100-10,900-9,400-5,500-8,400-17,100-13,432
00000000000000000000000000
0.02-0.02-0.010.020.020.030.050.060.090.250.30.310.330.360.40.460.530.590.620.740.861.031.211.381.421.48
0.62.24.44.862.94.578.810.19.410.313.21118.316.519.422.627.148.33846.440.371.563.445.03
8.517.316.114.511.79.57.47.211.219.117.919.414.416.223.626.732.237.246.94669.892125.6192.3224.9188.29
22.230.429.132.831.331.421.719.633.528.63028.830.533.441.249.260.764.898.595.796.798.6110.6124.2140.1134.48
00000000000000000000000000
00.1001.20.30000000000008.415.2000488.200
31.35049.652.150.244.133.633.853.557.857.358.558.160.683.192.4112.3124.6180.9205.2204.5237276.5876.2428.4367.79
08.48.400.30000000000000245.7194.9135.450467.20566.6569.66
0000000000000026.528.230.521.851.641.441.539.139.651.72.11.62
0.10.80.80.44.15.612.211.411.11617.621.419.820.324.722.927.329.925.320.520.169.573.767.983.598.85
0.19.29.20.44.45.612.211.411.11617.621.419.820.351.251.157.851.7322.6256.8197158.6580.5119.6652.2670.13
0.030.060.060.050.050.050.050.050.060.070.070.080.080.080.130.140.170.180.50.460.40.40.8611.081.04
0.050.040.040.070.070.080.10.10.150.330.370.390.410.440.530.60.70.761.121.21.271.432.062.382.52.52
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Omnicell provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Omnicell's financial health and stability.

Assets

Omnicell's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Omnicell must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Omnicell after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Omnicell's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
-90-26-20-1-5710-2104312041016243030930376132775-20
112222344349988131820255851515361738687
0000000000-24-6520201-1-5-31-5-1-6-3-37-11
449-2-131-2-20-6-7-4-2027-12-2-1-1-33-35-49-10-1537-3-7343
00101120121218291215191824273141456081106140164136
002110000000000000056730111
000000000001010679111173710-11920
-36-5-19-1017-4-119371446203139556538492410414518523177181
-1-1-60-2-3-2-5-2-3-7-13-6-9-13-20-20-22-20-29-30-54-61-54-58-60-55
5-701-72-14-88-3-34-13-6-23-13-168-20-43-45-341-35-54-61-279-412-58-55
7-561-45-11-3110-2700-130-1480-20-25-312-400-225-35420
000000000000000000000000000
0000-703000000000000249-48-77-9040900-2
00-42433168315105-5747-5-33-2-32174470785267-1223
00-32425197315105-5098-1070-36263-9-13-2345647-2123
000000000006513332-3-3-5-6-12-5-20-83
000000000000000000000000000
30-97743-51031108-4948616-1294221-43-27-223460362-134-2148
-54.9-11.2-19.6-13.6-2.45-9.5-4.715.730.20.739.511.318.118.934.842.618.420.7-5.749.683.3131173.517.1126.08
000000000000000000000000000

Omnicell stock margins

The Omnicell margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Omnicell. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Omnicell.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Omnicell's sales revenue. A higher gross margin percentage indicates that the Omnicell retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Omnicell's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Omnicell's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Omnicell's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Omnicell. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Omnicell's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Omnicell Margin History

Omnicell Gross marginOmnicell Profit marginOmnicell EBIT marginOmnicell Profit margin
2029e43.58 %0 %0 %
2028e43.58 %0 %0 %
2027e43.58 %0 %0 %
2026e43.58 %5.74 %6.93 %
2025e43.58 %6.1 %6.4 %
2024e43.58 %5.66 %5.78 %
202343.58 %-1.69 %-1.78 %
202246.07 %1.58 %0.43 %
202149.03 %8.08 %6.87 %
202046.62 %5.1 %3.61 %
201948.71 %8.74 %6.83 %
201847.29 %5.64 %4.79 %
201744.7 %1.56 %4.28 %
201645.57 %3.08 %1.41 %
201551.16 %9.33 %6.36 %
201453.05 %11.25 %6.92 %
201353.44 %9.27 %6.31 %
201254.33 %8.63 %5.16 %
201155.32 %6.6 %4.24 %
201053.06 %4.81 %2.2 %
200949.84 %1.5 %0.19 %
200851.05 %6.87 %5.04 %
200753.17 %8.54 %20.32 %
200655.27 %6.01 %6.72 %
200555.14 %-1.89 %-1.73 %
200458.03 %8.64 %8.56 %

Omnicell Stock Sales Revenue, EBIT, Earnings per Share

The Omnicell earnings per share therefore indicates how much revenue Omnicell has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Omnicell earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Omnicell's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Omnicell’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Omnicell's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Omnicell Revenue, EBIT and net profit per share

DateOmnicell Sales per ShareOmnicell EBIT per shareOmnicell Earnings per Share
2029e49.08 undefined0 undefined0 undefined
2028e41.77 undefined0 undefined0 undefined
2027e36.31 undefined0 undefined0 undefined
2026e26.7 undefined0 undefined1.85 undefined
2025e25.38 undefined0 undefined1.62 undefined
2024e24.2 undefined0 undefined1.4 undefined
202325.37 undefined-0.43 undefined-0.45 undefined
202228.23 undefined0.45 undefined0.12 undefined
202123.63 undefined1.91 undefined1.62 undefined
202020.42 undefined1.04 undefined0.74 undefined
201920.91 undefined1.83 undefined1.43 undefined
201819.39 undefined1.09 undefined0.93 undefined
201718.42 undefined0.29 undefined0.79 undefined
201618.86 undefined0.58 undefined0.27 undefined
201513.2 undefined1.23 undefined0.84 undefined
201412.05 undefined1.36 undefined0.83 undefined
201310.63 undefined0.99 undefined0.67 undefined
20129.18 undefined0.79 undefined0.47 undefined
20117.2 undefined0.48 undefined0.3 undefined
20106.64 undefined0.32 undefined0.15 undefined
20096.65 undefined0.1 undefined0.01 undefined
20087.61 undefined0.52 undefined0.38 undefined
20076.3 undefined0.54 undefined1.28 undefined
20065.35 undefined0.32 undefined0.36 undefined
20054.69 undefined-0.09 undefined-0.08 undefined
20044.47 undefined0.39 undefined0.38 undefined

Omnicell business model

Omnicell Inc. is a leading company in the healthcare industry, specializing in the development and provision of innovative automation solutions for medication and other critical medical supplies. The company was founded in 1992 and is headquartered in Mountain View, California, USA. Over the years, Omnicell has grown into a global company with offices in North America, Europe, Asia, and the Middle East. Omnicell's business model is to offer products, services, and solutions that allow healthcare facilities to optimize their processes, increase patient safety, and save costs. Omnicell provides innovative automation solutions, particularly for medication management, sterilization, and inventory control. Omnicell offers various solutions to improve medication management in clinics. This includes, for example, the medication cabinet, which has an integrated computer system that allows for the quick and easy identification and retrieval of needed medications. Omnicell also offers solutions for sterilizing medical materials to ensure patient safety, as well as automated storage systems for managing medical supplies. In recent years, the company has focused heavily on developing solutions to improve patient safety. One example is Omnicell's Medical Intelligence platform, which automatically detects and notifies of medication errors and other issues, thereby enhancing patient safety. Omnicell's products are used by a wide range of healthcare facilities, from small doctor's offices to large hospitals and health centers. The company has also established relationships with major retailers to sell its products, such as CVS and Walgreens in the USA. In addition to its core products and services, Omnicell also provides training and support to customers to ensure they can make optimal use of their products. The company also has its own research and development department to continuously develop new and innovative products and solutions. Overall, Omnicell aims to transform the healthcare industry through innovative automation solutions. Through its products, services, and solutions, the company has already helped many healthcare facilities improve their processes and increase patient safety. Omnicell will continue to invest in the development of new products and technologies to optimize the healthcare industry in the long term. Omnicell is one of the most popular companies on Eulerpool.com.

Omnicell Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Omnicell Revenue by Segment

Segmente202320222021202020192018
Product revenues708.56 M USD903.22 M USD812.51 M USD636.03 M USD--
Services and other revenues438.55 M USD392.73 M USD319.51 M USD256.18 M USD--
Product----659.6 M USD-
Product revenues-----569.6 M USD
Service----237.43 M USD217.71 M USD
Connected devices, software licenses, and other623.58 M USD827.92 M USD739.07 M USD560.37 M USD--
Technical services225.83 M USD206.69 M USD206.99 M USD202.38 M USD--
Advanced Services212.72 M USD186.04 M USD----
Consumables84.98 M USD75.31 M USD73.44 M USD75.66 M USD--
SaaS, subscription software, and technology-enabled services--112.52 M USD53.79 M USD--

Omnicell Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Omnicell Revenue by Segment

DateForeign CountriesOther CountriesRest of worldUnited States
2023--135.73 M USD1.01 B USD
2022--127.75 M USD1.17 B USD
2021--111.23 M USD1.02 B USD
2020--94.61 M USD797.6 M USD
2019--90.13 M USD806.9 M USD
2017-98.9 M USD-617.27 M USD
2016-101.06 M USD-591.57 M USD
2015-81.18 M USD-403.38 M USD
201446.67 M USD--394.23 M USD

Omnicell SWOT Analysis

Strengths

Omnicell Inc possesses several strengths that contribute to its success in the market:

  • Strong technological capabilities and innovative solutions
  • Established reputation and trusted brand in the healthcare industry
  • Extensive product portfolio catering to diverse customer needs
  • Global presence and a wide customer base
  • Strong financial position and steady revenue growth

Weaknesses

Despite its strengths, Omnicell Inc also faces certain weaknesses that can hinder its growth:

  • Dependency on a limited number of key customers
  • Reliance on external suppliers for critical components
  • High costs of research and development
  • Potential vulnerability to regulatory changes in the healthcare industry
  • Limited market share in certain geographic regions

Opportunities

Omnicell Inc can leverage the following opportunities to further expand its business:

  • Increasing demand for automated medication management systems
  • Growing adoption of cloud-based healthcare solutions
  • Expansion into emerging markets with untapped potential
  • Strategic partnerships and acquisitions to enhance product offerings
  • Advancements in artificial intelligence and machine learning technologies

Threats

Omnicell Inc faces the following threats that could negatively impact its performance:

  • Intense competition from established players and new entrants
  • Potential cybersecurity risks and data breaches
  • Volatility in healthcare policies and reimbursement systems
  • Economic downturns affecting healthcare spending
  • Rapid technological advancements leading to product obsolescence

Omnicell Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Omnicell historical P/E ratio, EBIT multiple, and P/S ratio

Omnicell shares outstanding

The number of shares was Omnicell in 2023 — This indicates how many shares 45.212 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Omnicell earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Omnicell's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Omnicell’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Omnicell's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Omnicell.

Omnicell latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20240.15 0.51  (245.53 %)2024 Q2
3/31/2024-0.1 0.03  (131.35 %)2024 Q1
12/31/20230.16 0.33  (111 %)2023 Q4
9/30/20230.48 0.62  (30.53 %)2023 Q3
6/30/20230.29 0.57  (97.99 %)2023 Q2
3/31/20230.07 0.39  (464.4 %)2023 Q1
12/31/20220.09 0.33  (249.58 %)2022 Q4
9/30/20220.97 1  (2.72 %)2022 Q3
6/30/20220.87 0.84  (-3.11 %)2022 Q2
3/31/20220.7 0.83  (18.79 %)2022 Q1
1
2
3
4
5
...
10

Eulerpool ESG Scorecard© for the Omnicell stock

Eulerpool World ESG Rating (EESG©)

69/ 100

🌱 Environment

98

👫 Social

85

🏛️ Governance

23

Environment

Scope 1 - Direct Emissions
414
Scope 2 - Indirect emissions from purchased energy
5,131
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
5,545
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
✅
Environmentally friendly packaging
✅
Hazardous substances
✅
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees38
Percentage of women in management—
Percentage of Asian employees15
Share of Asian management—
Percentage of Hispanic/Latino employees6
Hispano/Latino Management share—
Percentage of Black employees11
Black Management Share—
Percentage of white employees60
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Omnicell shareholders

%
Name
Stocks
Change
Date
4.37576 % State Street Global Advisors (US)2,012,411133,82212/31/2023
3.28761 % Champlain Investment Partners, LLC1,511,970-72,45012/31/2023
2.57875 % ClearBridge Investments, LLC1,185,967-148,91612/31/2023
2.32119 % Dimensional Fund Advisors, L.P.1,067,51621,79812/31/2023
2.30056 % Pacer Advisors, Inc.1,058,0271,057,69812/31/2023
2.16936 % Geode Capital Management, L.L.C.997,68951,58412/31/2023
2.04163 % Geneva Capital Management LLC938,944-41,59012/31/2023
15.56746 % BlackRock Institutional Trust Company, N.A.7,159,473256,76212/31/2023
12.09245 % The Vanguard Group, Inc.5,561,317434,33612/31/2023
1.94281 % Macquarie Investment Management893,499108,33712/31/2023
1
2
3
4
5
...
10

Omnicell Executives and Management Board

Mr. Randall Lipps65
Omnicell Chairman of the Board, President, Chief Executive Officer (since 1992)
Compensation 7.9 M
Mr. Corey Manley45
Omnicell Senior Vice President, Chief Legal Officer
Compensation 1.3 M
Ms. Joanne Bauer67
Omnicell Lead Independent Director
Compensation 323,574
Mr. Mark Parrish67
Omnicell Independent Director
Compensation 287,540
Mr. Robin Seim63
Omnicell Independent Director (since 2006)
Compensation 282,540
1
2
3

Omnicell Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Twilio A Stock
Twilio A
SupplierCustomer0,590,550,830,970,620,24
Ensign Group Stock
Ensign Group
SupplierCustomer0,41-0,170,78-0,19-0,240,73
Premier A Stock
Premier A
SupplierCustomer0,240,05-0,520,750,630,74
Walmart Stock
Walmart
SupplierCustomer-0,080,40-0,92-0,52-0,270,38
Community Health Systems Stock
Community Health Systems
SupplierCustomer-0,090,220,840,760,600,86
Costco Wholesale Stock
Costco Wholesale
SupplierCustomer-0,140,39-0,66-0,25-0,300,57
Walgreens Boots Alliance Stock
Walgreens Boots Alliance
SupplierCustomer-0,200,220,660,450,310,70
CVS Health Stock
CVS Health
SupplierCustomer-0,280,340,32-0,57-0,500,62
BIO-key Stock
BIO-key
SupplierCustomer-0,310,410,750,400,35-0,58
Fresenius Stock
Fresenius
SupplierCustomer-0,620,26-0,660,340,290,04
1

Most common questions regarding Omnicell

What values and corporate philosophy does Omnicell represent?

Omnicell Inc represents a strong commitment to improving patient care and safety through innovative medication management solutions. The company's corporate philosophy revolves around optimizing workflows and ensuring the right medication is delivered to the right patient at the right time. Omnicell is dedicated to enhancing operational efficiency, reducing medication errors, and promoting adherence to medication regimens. Their values include prioritizing patient-centricity, fostering a culture of collaboration, and driving continuous innovation in healthcare technology. Omnicell Inc strives to revolutionize medication management processes, ultimately helping healthcare organizations deliver better patient outcomes and improve overall healthcare efficiency.

In which countries and regions is Omnicell primarily present?

Omnicell Inc is primarily present in the United States.

What significant milestones has the company Omnicell achieved?

Omnicell Inc has achieved several significant milestones since its inception. The company has become a global leader in automated healthcare solutions, catering to hospitals, pharmacies, and healthcare organizations. Omnicell's product portfolio includes advanced medication management systems, robotics, and software solutions improving patient safety and operational efficiency. The company has successfully expanded its global presence, established strategic partnerships, and received multiple industry accolades. Moreover, Omnicell has consistently focused on research and development, resulting in innovative technologies and improved patient outcomes. With its dedication to advancing healthcare through technology, Omnicell Inc continues to drive positive change in the industry.

What is the history and background of the company Omnicell?

Omnicell Inc, a leading provider of medication management solutions, has a rich history and background. Established in 1992, Omnicell has continuously delivered innovative technologies to enhance patient safety and improve healthcare outcomes. The company's journey started with automated dispensing systems for medication storage and administration. Over the years, Omnicell expanded its product portfolio to include advanced solutions like robotic automation, analytics, and interoperability, catering to various healthcare settings globally. Today, Omnicell is renowned for its commitment to optimizing medication management processes, reducing errors, improving efficiency, and enabling healthcare professionals to focus on patient care. With a strong track record and dedication to innovation, Omnicell Inc has established itself as a trusted name in the healthcare industry.

Who are the main competitors of Omnicell in the market?

Omnicell Inc faces competition from various companies in the market. Some of its main competitors include McKesson Corporation, BD (Becton, Dickinson and Company), and Cantel Medical Corp. These companies operate in the healthcare solutions industry and provide similar products and services, which directly compete with Omnicell Inc. Additionally, companies like Capsa Healthcare and Baxter International Inc. also pose competition in certain segments. However, Omnicell Inc's strong market presence, innovative technologies, and comprehensive range of solutions help them remain competitive in the industry.

In which industries is Omnicell primarily active?

Omnicell Inc is primarily active in the healthcare industry.

What is the business model of Omnicell?

Omnicell Inc is a leading healthcare technology company specializing in medication and supply management solutions. The company's business model revolves around providing automated systems and software solutions to hospitals, pharmacies, and other healthcare institutions. Omnicell aims to streamline workflow, improve patient safety, and optimize inventory management through its innovative technology and services. By offering a comprehensive suite of products, including medication dispensing cabinets, inventory management systems, and analytics software, Omnicell enhances operational efficiency and patient care quality. With its patient-centric approach, Omnicell Inc continues to be a trusted partner in the healthcare industry, delivering valuable solutions and improving overall healthcare outcomes.

What is the P/E ratio of Omnicell 2024?

The Omnicell P/E ratio is 29.97.

What is the P/S ratio of Omnicell 2024?

The Omnicell P/S ratio is 1.73.

What is the Quality Investing of Omnicell?

The Quality Investing for Omnicell is 4/10.

What is the revenue of Omnicell 2024?

The expected Omnicell revenue is 1.11 B USD.

How high is the profit of Omnicell 2024?

The expected Omnicell profit is 64.3 M USD.

What is the business model of Omnicell

Omnicell Inc. is a US-based company that has gained worldwide recognition for its automation solutions for healthcare providers. The company positions itself as a reliable provider of innovative products and services in this field. The main products and services of Omnicell Inc. fall into four main areas: medication management, central pharmacy systems, workflow optimization, and analytics solutions. The medication management is the core of Omnicell Inc.'s business model. The company offers a variety of solutions for various areas including hospitals, pharmacies, and long-term care facilities to better automate medication inspection, preparation, dispensing, and returns. These solutions help nursing staff save time, minimize errors, and better meet patient needs. Central pharmacy systems are another important pillar of Omnicell Inc. These systems are designed to automate the workflow of pharmacies and distribution centers by monitoring and managing inventory and orders, optimizing product assignment to patients, and providing real-time data for inventory management. Workflow optimization is an important aspect of Omnicell Inc.'s business model. The company aims to increase the efficiency of nursing staff by automating workflows, reducing workload, and improving the quality of patient care. The company has developed a wide range of solutions for this purpose, including automated documentation, inventory management, and patient assignment. Analytics solutions also play an important role in Omnicell Inc.'s business strategy. The company offers innovative analysis tools that monitor prescription dispensing and collect data to optimize medication inventory and orders. These tools provide important business-relevant information that contributes to higher ROI in the healthcare industry. Overall, the company offers a wide range of products and services aimed at increasing efficiency, accuracy, and effectiveness in healthcare. Omnicell Inc. aims to meet the needs of providers and patients alike while ensuring the highest level of reliability, efficiency, and safety. With its innovative products, strong focus on customer service, and continuous investment in research and development, Omnicell Inc. has established itself as a market leader in automation solutions for healthcare providers.

What is the Omnicell dividend?

Omnicell pays a dividend of 0 USD distributed over payouts per year.

How often does Omnicell pay dividends?

The dividend cannot currently be calculated for Omnicell or the company does not pay out a dividend.

What is the Omnicell ISIN?

The ISIN of Omnicell is US68213N1090.

What is the Omnicell WKN?

The WKN of Omnicell is 632313.

What is the Omnicell ticker?

The ticker of Omnicell is OMCL.

How much dividend does Omnicell pay?

Over the past 12 months, Omnicell paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Omnicell is expected to pay a dividend of 0 USD.

What is the dividend yield of Omnicell?

The current dividend yield of Omnicell is .

When does Omnicell pay dividends?

Omnicell pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Omnicell?

Omnicell paid dividends every year for the past 0 years.

What is the dividend of Omnicell?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Omnicell located?

Omnicell is assigned to the 'Health' sector.

Wann musste ich die Aktien von Omnicell kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Omnicell from 10/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/13/2024.

When did Omnicell pay the last dividend?

The last dividend was paid out on 10/13/2024.

What was the dividend of Omnicell in the year 2023?

In the year 2023, Omnicell distributed 0 USD as dividends.

In which currency does Omnicell pay out the dividend?

The dividends of Omnicell are distributed in USD.

All fundamentals about Omnicell

Our stock analysis for Omnicell Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Omnicell Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.